MyBack - A Behavior Change Informed Exercise Program to Prevent Low Back Pain Recurrences
Launched by INSTITUTO POLITÉCNICO DE SETÚBAL · Apr 24, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The MyBack trial is studying a special exercise program designed to help people who have recently recovered from low back pain (LBP) prevent it from coming back. Low back pain is very common and can be costly, so finding effective ways to keep it from returning is important. The MyBack program includes tailored exercises and focuses on changing behaviors to support recovery. Researchers want to see how well this program works, how easy it is for people to follow, and what factors influence its success in different healthcare settings.
To participate in this study, you need to be between 18 and 65 years old and have fully recovered from non-specific low back pain in the last three months, meaning you should have a low pain score for at least 30 days. You also need to speak Portuguese and have a mobile phone that can send and receive texts. If you join the study, you’ll be part of a larger group working together to understand how this exercise program can help prevent future back pain. It's a great opportunity to contribute to research that could benefit many others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Recovered (within the last 3 months) from an episode of non-specific LBP (with or without leg pain and of any duration)
- • Recovery from an LBP episode is defined as having a pain score of "0" or "1" on a 11-point Numeric Pain Rating Scale for, at least, 30 consecutive days
- • Age between 18 and 65 years;
- • Read and speak the Portuguese language;
- • Having a mobile phone capable of receiving and sending text messages;
- • No medical contraindication to exercise.
- Exclusion Criteria:
- • Diagnosis, or symptoms consistent with, severe depression or other psychiatric condition,
- • Pregnancy
- • Spinal surgery in the last 6 months
About Instituto Politécnico De Setúbal
Instituto Politécnico de Setúbal (IPS) is a prominent higher education institution in Portugal, dedicated to fostering academic excellence and innovative research in various fields, including healthcare and clinical studies. With a strong commitment to advancing knowledge and improving public health outcomes, IPS actively engages in clinical trials that contribute to evidence-based practices and the development of new therapeutic interventions. The institute's multidisciplinary approach and collaboration with industry partners and healthcare organizations position it as a key player in the advancement of clinical research in the region, ensuring the integrity and quality of its trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Setúbal, , Portugal
Patients applied
Trial Officials
Eduardo Cruz, PhD
Principal Investigator
Instituto Politécnico de Setúbal
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported